RAS LSS Consulting’s Post

View organization page for RAS LSS Consulting, graphic

4,711 followers

🔬 Big News! 🔬   #Genmab A/S (Nasdaq: GMAB) announces the agreement to acquire #ProfoundBio, Inc., a clinical-stage biotech innovator, in an all-cash transaction worth USD 1.8 billion. This strategic move fortifies Genmab's pipeline with cutting-edge #ADC technology, including Rina-S, targeting #ovariancancer and #solidtumors expressing #FRα.   This move aligns with #Genmab's vision to innovate in antibody medicines. The transaction is expected to close in the first half of 2024, subject to regulatory approval.   #Genmab #ProfoundBio #CancerTherapy #Innovation #Healthcare   Detailed News: https://lnkd.in/dypz57dw   Follow our page for more industry updates: https://lnkd.in/de5zNWmK

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

globenewswire.com

To view or add a comment, sign in

Explore topics